ANTI-MICROBIAL USAGE IN THE COMMUNITY AND RESISTANCE IN E.COLI

Slides:



Advertisements
Similar presentations
ICIUM 2011 | 1 |1 | Behavioural Model for Community-Based Antimicrobial Resistance, Vellore, India Dele Abegunde 1 ; Holloway, Kathleen 1 ; Mathai, Elizabeth.
Advertisements

RATIONAL USE OF INJECTION: An Integrated Tool For Monitoring Injection Prescription in the Kingdom of CAMBODIA Dr Sok Srun Department of Hospitals, MoH.
BACTERIOLOGY & ANTIBIOTIC SENSITIVITY PATTERNS OF URINARY TRACT INFECTION IN A TERTIARY HOSPITAL IN BANGLADESH Professor Md. Mahabubul Islam Majumder Department.
Primary Care Management of Urinary Tract Infection in Pregnant Women Dr. Charlotte Cooke Northumbria Healthcare NHS Foundation.
THE INAPPROPRIATE SALE OF MEDICATION FOR PEDIATRIC USE IN SIEM REAP PROVINCE, KINGDOM OF CAMBODIA AUTHORS: Sothearith Tiv Ph., Rathi Guhadasan MBBS MRCP.
المضادات الحيوية.....الى أين؟ اليوم العلمي Presented by: Dalia qishawi Trends in Antimicrobial Resistance among Urinary Tract Infection Pathogens Isolated.
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
WHO local pilot projects to contain AMR ICIUM 2004 K.A.Holloway and T.L.Sorensen Essential Drugs and Medicines Policy WHO Geneva.
Antibiotic Prescribing Practices of Primary Care Prescribers for Acute Respiratory Tract Infections and Diarrhoea in New Delhi, India Anita Kotwani 1,
The Antibiotic Sensitivity Test Presented by Marian Mikhail Undergraduate student Biology Major Health and Science Concentration Health and Science Concentration.
Using Longitudinal Data for Evaluating Policy Changes and Other Interventions -Information system in Tamilnadu Medical Services Corporation.
Economic Burden and Health Consequences of Antibiotic Resistance in Patients at a Tertiary Care Hospital, Vellore, South India Sujith J Chandy (1,2), Thomas.
DR.M.F MOUSSA B.Sc,M.B.B.S Diplomé en Santé Publique Victoria Hospital,Candos.
Adham Abu Taha, PhD Dept. of Pharmacology and Toxicology, College of Pharmacy, An-Najah National University, Nablus, Palestine Antimicrobial resistance.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Methods for AMR Surveillance in Communities – lessons from the Durban site Gray AL and Essack SY Department of Pharmacology, Nelson R Mandela School of.
Surveillance of antimicrobial use in resource-constrained community settings Kathleen Holloway, Elizabeth Mathai and Andy Gray on behalf of on behalf of:
Cambodia1. 2 Cambodia Assessment Ung Phirun Chroeng Sokhan.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
Incidence of hospitalisations in both groups Incidence of documented infections Abstract Problem statement: Patients on cancer chemotherapy are at substantial.
Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.
Challenges in Setting up a District-Based Antimicrobial Use Surveillance Programme Gous AGS, Van Deventer WV, Pochee E, Tumbo JM, Sorenson TL, Holloway.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Methodological challenges for AMR surveillance programmes Gous AGS, Pochee E School of Pharmacy Medical University of Southern Africa.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
1 COMMUNITY INTERVENTION TO PROMOTE RATIONAL TREATMENT OF ACUTE RESPIRATORY INFECTION IN RURAL NEPAL Karkee SB, Tamang AL, Gurung YB, Holloway KA, Kafle.
ICIUM 2004-CHIANG MAI SURVEY REPORT ON RATIONAL USE OF DRUGS In 30 Primary Health Centres of Tamilnadu, India.
Medicines use in children under 5 years primary care in developing and transitional countries Results from studies reported between Kathleen.
SURVEILLANCE OF ANTIMICROBIAL USE AT ALL LEVELS OF THE HEALTH SECTOR: AN INTERVENTION IN ITSELF? Thatte UM, Kulkarni RA, Holloway K, Sorenson T, Koppikar.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.
Surveillance of Antimicrobial Resistance and Use In The Community Methodological Issues Thatte UM, Kulkarni RA, Holloway K, Sorenson T, Koppikar GV, Shinkre.
100% Ciprofloxacin resistance in gonococcal isolates in patients with or at high risk of HIV acquisition in an urban Ugandan clinic DR EMILY MABONGA KING’S.
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Kiran Ghimire, Baral B., Karna S., Baral M.P. PhD
ANTI-MICROBIAL USAGE IN THE COMMUNITY AND RESISTANCE IN E.COLI
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
به نام و یاد خالق هستی هم او که آفرید شور و مستی.
Management of Urinary Tract Infections Renal Block
Management of Urinary Tract Infections Renal Block
Family Medicine Development in the Land of Colors and Wonders
Prescribing indicators Total number of drugs/encounters (n)
Evaluating Australia‘s National Strategy for Quality Use of Medicines
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
Average susceptibility
Bacteraemia in Buckinghamshire Healthcare NHS Trust
Powys teaching Health Board
Average Monthly Temperature and Rainfall
به نام و یاد خالق هستی هم او که آفرید شور و مستی.
2016 FIT FOR PERFORMANCE Weight Control Program
Kandeke C, Chibuta C, Banda D
Neonatal sepsis in Kilifi
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
Improving Antibiotic use through a Nationwide Decentralized Project –
Swedres 2007 Figures and tables Swedres 2007.
“I don’t get calls like that anymore.”
ASSESSMENT OF CONSUMERS DRUG KNOWLEDGE IN ADDIS ABABA: CROSS-SECTIONAL SURVEY
“Bug of the month “ Pseudomonas aeruginosa (Gram negative bacilli)
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
Type of provider/facilities Private Sector Providers
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
ANTIMICROBIAL USE AND RESISTANCE SURVEILLANCE PILOT PROJECT – LESSONS FROM THE DURBAN SITE Gray AL, Essack SY, Deedat F, Pillay T, van Maasdyk J, Holloway.
WHO Community drug use practices in malaria in Cambodia: a cross-sectional study National Malaria Centre of Cambodia Rational Pharmaceutical Management.
Impact of Microbial Culture Analysis and Prophylactic use of Antibiotics in Acute Severe Pancreatitis Jagadish babu Dasari, Cristiano Ialongo, Aruna Chandranath.
Scottish One Health Antimicrobial Use and Resistance in 2017 Annual Report
Tony Crockford & Muhammad Sartaj.
David RP Terry Birmingham Children’s Hospital
Is Primary Care Safe? HAPIA Conference 2014 Peter Walsh
New Antibiotic guidelines April 2013
Pharmacy Integration Improving care in care homes
Presentation transcript:

ANTI-MICROBIAL USAGE IN THE COMMUNITY AND RESISTANCE IN E.COLI FROM URINE OF PREGNANT WOMEN IN INDIA Thomas K1, Mathai E1, Mathai M1, Chandy SJ1, Joseph I1, Oommen R1, Mathew J1, Antonisamy B1, Banerjee M1, Cherian S1, Rajaratnam A1 Holloway K2, Sorensen T2 1Rational Antimicrobial Use Study Team, Christian Medical College, Vellore, India 2WHO, Geneva

A GOOD DOCTOR KNOWS WHAT MEDICINE TO PRESCRIBE… A BETTER DOCTOR KNOWS WHAT NOT TO PRESCRIBE…

INTRODUCTION Increasing resistance to anti-microbial agents Increasing use of antimicrobials Monitoring the relationship an important tool : - to determine the association - to demonstrate need for rational drug use  - to identify target areas for intervention

AIM Phase 1: To establish an integrated surveillance model of anti-microbial resistance and use Phase 2: To develop an intervention to improve rational antimicrobial use and contain resistance.      

METHODS A. ANTIMICROBIAL USAGE Geographical areas: 1. Urban area - Vellore town 2. Rural area - KV Kuppam block Drug usage was studied using two methodologies: 1. Individual Patient Drug Use 2. Bulk Drug Use

1. Individual Drug Use 15 facilities in each area- private practitioners, hospitals and pharmacy shops Monthly visit - structured questionnaire format 30 patients prescribed or dispensed any antimicrobial included per facility Main outcome measure: - Percentage of patients prescribed a specific antimicrobial       

2. Bulk Drug Use 5 pharmacy shops in each area : - purchase and sales data 5 hospitals (PHCs and RUHSA)in rural area : - drug stock register CMC hospital (tertiary care) in urban area : - pharmacy computer system The DDD/1000 patients /month : - calculated for a specific antimicrobial

B. ANTIMICROBIAL RESISTANCE: 100 women recruited per month from antenatal clinics 1. CMC Hospital, Vellore (urban) 2. RUHSA hospital, KV Kuppam Block (rural).   Women symptomatic of UTI - midstream urine cultured Asymptomatic women - deliberate contamination of urine Cultured in Maconkey agar. Susceptibility test in isolates - for antimicrobials used in gram negative infections Primary microbiological outcome : - Percentage of isolates resistant to specific antimicrobials

RESULTS Antimicrobial Usage Pattern 5400 patients (47.3 %) given antimicrobials - from a total of 11,421 patient encounters. 406 patients (7.5 %) given more than one antimicrobial. 2091 patients (38.7 %) had at least one injection The commonly prescribed antimicrobials were: Fluoroquinolones – 14.0 % Cotrimoxazole – 7.1 % Amoxycillin/Ampicillin – 11.4%   Cephalosporins – 5.6 %  

Preliminary Data Analysis of Resistance in E. coli : 535 consecutive E. coli isolated from contaminated urine E. coli resistance determined for specific antimicrobials: Cotrimoxazole – 23.8 % Chloramphenicol – 7.8 % Tetracyclines – 21.0 % Norfloxacin – 3.8 % Ampicillin – 20.1 % Cefalexin – 2.4 % Nalidixic acid – 18.3 % Nitrofurantoin – 0.6%

USE of ANTIMICROBIALS & RESISTANCE of E. coli - in RURAL & URBAN AREAS INDIVIDUAL DRUG USE 20 30 25 15 20 % Drug use 10 % Ecoli resistance 15 10 5 5 F’quinolones Nalidixic acid Tetracyclines Ampi / Amox Cephalexin Cotrimoxazole Rural drug use Urban drug use Rural resistance Urban resistance

USE of ANTIMICROBIALS & RESISTANCE of E. coli - in RURAL & URBAN AREAS BULK DRUG USE 30 600 25 500 400 20 % Ecoli resistance DDD / 1000 patients 300 15 200 10 100 5 Ampi / Amox Cephalexin Cotrimoxazole F'quinolones Nalidixic acid Tetracyclines Rural drug use Urban drug use Rural resistance Urban resistance

INDIVIDUAL patient USE of COTRIMOXAZOLE and RESISTANCE of E. coli - in health facilities RURAL AREA 60 60 50 50 40 40 30 % E.coli resistance 30 % Drug use 20 20 10 10 Aug Sept Oct Nov Dec Jan Pharmacy shop use GP use Hospital use E.coli resistance

INDIVIDUAL patient USE of COTRIMOXAZOLE and RESISTANCE of E. coli - in health facilities Pharmacy shop use GP use Hospital use E.coli Resistance URBAN AREA 1 2 3 4 5 6 Aug Sept Oct Nov Dec Jan % Drug use 10 15 20 25 30 35 % E.coli resistance

BULK USE of COTRIMOXAZOLE and RESISTANCE of E. coli - in health facilities RURAL AREA 200 400 600 800 1000 1200 1400 Aug Sep Oct Nov Dec Jan DDD / 1000 patients 5 10 15 20 25 30 35 % Ecoli resistance Pharmacy shop use Hospital use Ecoli resistance

BULK USE of COTRIMOXAZOLE and RESISTANCE of E. coli - in health facilities URBAN AREA 250 35 30 200 25 150 DDD / 1000 patients % Ecoli resistance 20 100 15 10 50 5 Aug Sep Oct Nov Dec Jan Pharmacy shop use CMC hospital use % Ecoli resistance

INDIVIDUAL patient USE of FLUOROQUINOLONES and RESISTANCE of E. coli - in health facilities RURAL AREA 30 8 7 25 6 20 5 15 % Ecoli resistance 4 % Drug use 3 10 2 5 1 Aug Sep Oct Nov Dec Jan Pharmacy shop use GP use Hospital use Ecoli resistance

INDIVIDUAL patient USE of FLUOROQUINOLONES and RESISTANCE of E. coli - in health facilities URBAN AREA 30 10 25 8 20 6 15 % Ecoli resistance % Drug use 4 10 2 5 Aug Sep Oct Nov Dec Jan Pharmacy shop use GP use Hospital use Ecoli resistance

BULK USE of FLUOROQUINOLONES and RESISTANCE of E. coli - in health facilities RURAL AREA 200 8 150 6 DDD / 1000 patients 100 4 % Ecoli resistance 50 2 Aug Sep Oct Nov Dec Jan Pharmacy shop use Hospital use % Ecoli resistance

BULK USE of FLUOROQUINOLONES and RESISTANCE of E. coli - in health facilities URBAN AREA 200 4 150 3 % Ecoli resistance DDD / 1000 patients 100 2 50 1 Aug Sep Oct Nov Dec Jan Pharmacy shop use CMC hospital use Ecoli resistance

INDIVIDUAL patient USE of AMPICILLIN / AMOXYCILLIN and RESISTANCE of E. coli - in health facilities RURAL AREA 5 10 15 20 25 30 35 Aug Sep Oct Nov Dec Jan % Drug use % Ecoli resistance Pharmacy shop use GP use Ecoli resistance Hospital use

INDIVIDUAL patient USE of AMPICILLIN / AMOXYCILLIN and RESISTANCE of E. coli - in health facilities Pharmacy shop use GP use Ecoli resistance Hospital use URBAN AREA 5 10 15 20 Aug Sep Oct Nov Dec Jan % Drug use 25 30 35 40 % Ecoli resistance

BULK USE of AMOXYCILLIN/AMPCILLIN and RESISTANCE of E. coli - in health facilities RURAL AREA 200 35 30 150 25 DDD / 1000 patients 20 % Ecoli resistance 100 15 10 50 5 Aug Sep Oct Nov Dec Jan Pharmacy shop use Hospital use Ecoli resistance

BULK USE of AMOXYCILLIN/AMPCILLIN and RESISTANCE of E. coli - in health facilities URBAN AREA 40 400 35 30 300 25 DDD / 1000 patients % Ecoli resistance 20 200 15 10 100 5 Aug Sep Oct Nov Dec Jan Pharmacy shop use CMC hospital use Ecoli resistance

Conclusions High levels of antimicrobial use in community - 43.7% Commonly used antimicrobials : Fluoroquinolones - general practice (private sector) Cotrimoxazole - rural hospitals ( mainly public sector) Amoxycillin / Ampicillin - pharmacy shops and general practice (private sector) Antimicrobials with higher resistance in E.coli are : Cotrimoxazole Ampicillin Tetracyclines Nalidixic acid

Resistance levels appear to be similar in both rural and urban areas At Phase I completion, conclusions to be drawn on : - antimicrobial use, resistance and their relationship - the facilities and antimicrobials needing interventions Phase I information can be used : - to plan multidimensional interventions targeting health administrators, providers and consumers (Phase II) The interventions may improve rational antimicrobial use and ultimately control bacterial resistance

A GOOD DOCTOR KNOWS WHAT MEDICINE TO PRESCRIBE… A BETTER DOCTOR KNOWS WHAT NOT TO PRESCRIBE… THE BEST DOCTOR KNOWS WHEN NOT TO PRESCRIBE..!

Thank You